Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-040452

Epizyme, Inc. · EPZM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David M Mott
Director
Period of report
Jul 2, 2018
Accepted (ET)
Jul 2, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001F1Jul 2, 2018A6,088$13.55A12,088D
Common Stock, par value $0.0001F2holding———6,054,351ISee Note 2
Common Stock, par value $0.0001F3holding———406,500ISee Note 3
Common Stock, par value $0.0001F4holding———651ISee Note 4

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses